Evaluation of Improvements in Patient-reported Quality of Life

Launched by FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL CLÍNICO DE VALENCIA · Aug 17, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how different treatment approaches can improve the quality of life for women with breast cancer. Specifically, it looks at how flexible treatment planning, supported by real-world data, compares to standard care in helping patients feel better and more satisfied with their treatment. The trial aims to measure improvements in areas like physical activity, sleep quality, stress, and pain.

To be eligible for this trial, participants should be women aged 18 to 75 who have been diagnosed with stage I-III breast cancer and have started endocrine treatment within the last year. They need to have a good life expectancy beyond three months after starting treatment and be able to understand and follow the trial's requirements. Participants will need to provide written consent to join the study. If you choose to participate, you will be part of a group that aims to find ways to enhance treatment satisfaction and overall well-being for breast cancer patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Before patient registration, written informed consent must be given according to national and local regulations.
• • Participants have had histologically proven stage I-III breast cancer undergoing endocrine treatment (with or without prior chemotherapy) no more than 12 months prior to randomization.
• • Be between 18 and 75 years of age.
• • Have increased life expectancy beyond the initial 3 months post-treatment initiation.
• • Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent.
• • Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.
• Exclusion Criteria:
• • Patients that are not willing to sign an informed consent form